同和药业(300636.SZ)：通过美国FDA现场检查

Core Viewpoint - The company, Tonghe Pharmaceutical, has successfully passed the cGMP inspection by the FDA, indicating compliance with U.S. drug production quality standards [1] Group 1: FDA Inspection - The company underwent an FDA cGMP inspection from August 4 to August 7, 2025, covering six major systems: quality system, materials, production, packaging and labeling, equipment facilities, and laboratory controls [1] - The company has received confirmation from the FDA's official website that it has passed the inspection [1]